Bangladesh signs deal for Sinopharm Covid vaccine
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
SUNDAY, MAY 29, 2022
SUNDAY, MAY 29, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
Bangladesh signs deal for Sinopharm Covid vaccine

Covid-19 in Bangladesh

TBS Report
12 June, 2021, 03:10 pm
Last modified: 12 June, 2021, 08:50 pm

Related News

  • 40 new cases reported in 24hrs
  • Venice has a 400-year-old Covid monetary lesson
  • 28 new Covid cases reported in a day
  • 23 new Covid cases reported in a day
  • Bangladesh reports 28 new Covid cases in 24hrs

Bangladesh signs deal for Sinopharm Covid vaccine

Health Minister Zahid Maleque did not disclose more on the issue – such as the date of the deal and the price of the doses – to avoid any controversy

TBS Report
12 June, 2021, 03:10 pm
Last modified: 12 June, 2021, 08:50 pm
Sinopharm has become the first non-Western vaccine that is approved by WHO. Photo: Reuters.
Sinopharm has become the first non-Western vaccine that is approved by WHO. Photo: Reuters.

The government has signed a deal to procure the Sinopharm Covid-19 vaccine from China, Health Minister Zahid Maleque said on Saturday.

He, however, did not disclose anything more on the issue – such as the date of the deal and the price of the doses.           

"The recent revelation of the vaccine price has created some issues. We have to maintain non-disclosure matters strictly," the health minister said while speaking at a programme in the National Institute of Cardiovascular Diseases.

On 27 May this year, the Cabinet Committee on Public Purchase approved a proposal for buying 1.5 crore doses of Sinopharm Covid-19 vaccine.

Right after the meeting, a Cabinet Division official told reporters at a briefing that the government would purchase the vaccine at $10 per dose. The price disclosure created confusion a week before the signing of the final deal for the vaccine.

In the interest of trade, China had earlier said that prices should not be disclosed under any circumstances as they are supplying vaccines to different countries of the world at different prices.

Sinopharm agreed to provide vaccines for $10 per dose because of good bilateral relations between China and Bangladesh, according to sources.

Sri Lanka was the first country that raised its voice after the news broke in the Bangladeshi media, as the country has to pay $15 to buy each dose of the same vaccine.

China has already issued a diplomatic letter to Bangladesh asking why the price was disclosed even after Bangladesh had been informed earlier that the supplier would suffer commercial losses if prices are revealed. China in its letter said its fears have come true, as many countries have already objected to them about vaccine prices.

Beijing has already said Bangladesh will have to pay $15 per dose to buy the vaccine now.

China on May 12 handed over five lakh doses of  Sinopharm Covid-19 vaccine to Bangladesh as a gift, while additional 6 lakh doses of the vaccine are scheduled for reaching Bangladesh on Sunday, according to the Chinese Embassy in Dhaka.

Hualong Yan, deputy chief of mission, Embassy of China in Bangladesh, confirmed the matter in his Facebook post on Friday.

"600,000 gift vaccines are heading to Beijing International Airport. Arrival in Dhaka: June 13," he wrote.

Moreover, Bangladesh will get some 10.8 lakh doses of Oxford-AstraZeneca vaccine soon under the Covid-19 Vaccines Global Access (Covax) facility. The country has been suffering an acute crisis of the AstraZeneca vaccine, as around 15 lakh people are waiting for the second dose of the vaccine.

But, even with the doses, there will still be a shortage of about five lakh of doses Covid-19 vaccine. If these doses are not arranged in time, some five lakh people's first dose will prove to be ineffective.

The government is trying to solve the crisis as soon as possible, said Foreign Minister Dr AK Abdul Momen while briefing the media on several occasions recently.

 

Bangladesh / Top News / Health

Covid -19 / Covid -19 in Bangladesh / Sinopharm

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Central bankers’ refusal to embark into ‘hard helicopter money’ experiment have been a good idea. Photo: Reuters
    Interbank exchange rate for dollar set at Tk89
  • A Regio regional passenger train operated by Deutsche Bahn AG travels on a bridge in Berlin. Photographer: Krisztian Bocsi/Bloomberg
    Why Germany is offering a summer of cheap trains
  • Patients opting to delay crucial treatment amid rising costs
    Patients opting to delay crucial treatment amid rising costs

MOST VIEWED

  • 40 new cases reported in 24hrs
    40 new cases reported in 24hrs
  • 28 new Covid cases reported in a day
    28 new Covid cases reported in a day
  • 23 new Covid cases reported in a day
    23 new Covid cases reported in a day
  • Illustration: Collected
    Bangladesh reports 28 new Covid cases in 24hrs
  • Illustration: Collected
    Bangladesh logs 30 new Covid cases in 24hrs
  • Illustration: Collected
    34 Covid cases reported in 24 hours

Related News

  • 40 new cases reported in 24hrs
  • Venice has a 400-year-old Covid monetary lesson
  • 28 new Covid cases reported in a day
  • 23 new Covid cases reported in a day
  • Bangladesh reports 28 new Covid cases in 24hrs

Features

Central bankers’ refusal to embark into ‘hard helicopter money’ experiment have been a good idea. Photo: Reuters

Venice has a 400-year-old Covid monetary lesson

3h | Panorama
Aiman R Khan. Illustration: TBS

Why ‘marry your rapist’ court orders are not always what they seem

5h | Thoughts
Photo: Collected

Top 3 The Ordinary products that give extraordinary results

7h | Mode
Photo: Courtesy

KVN Beauty: Channel your inner Bangalee baddie

7h | Mode

More Videos from TBS

Paper industry worth thousands of crores in Bogura

Paper industry worth thousands of crores in Bogura

2h | Videos
Photo: TBS

Tips to help you become a successful lawyer

8h | Videos
Photo: TBS

Harassment over 'indecent clothing': Women gather at Narsingdi railway station to protest, show solidarity

8h | Videos
People bid adieu to Abdul Gaffar Chowdhury

People bid adieu to Abdul Gaffar Chowdhury

8h | Videos

Most Read

1
Bangladesh Bank GM, DGM’s designation changed
Banking

Bangladesh Bank GM, DGM’s designation changed

2
Corporates go cashless…tax cut on cards
NBR

Corporates go cashless…tax cut on cards

3
Photo: Courtesy
Panorama

Misfit Technologies: A Singaporean startup rooted firmly in Bangladesh

4
British International Investment (BII) CEO Nick O’Donohoe. Illustration: TBS
Economy

BII to invest $450m in Bangladesh in 5 years

5
Representational image. Picture: Pixabay
Economy

Govt raises regulatory duty to discourage imports of 130 products

6
Photo: Collected
Industry

Spanish recycled cotton producer opens new facility in Bangladesh

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab